Year |
Citation |
Score |
2013 |
Vanderhoek M, Perlman SB, Jeraj R. Impact of different standardized uptake value measures on PET-based quantification of treatment response. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1188-94. PMID 23776199 DOI: 10.2967/Jnumed.112.113332 |
0.662 |
|
2012 |
Vanderhoek M, Perlman SB, Jeraj R. Impact of the definition of peak standardized uptake value on quantification of treatment response. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 4-11. PMID 22213818 DOI: 10.2967/Jnumed.111.093443 |
0.639 |
|
2012 |
Scully P, Vanderhoek M, Perlman S, Liu G, Jeraj R. WE-C-BRA-07: Assessment of Heterogeneous Treatment Response in Patients with Multiple Solid Tumors Medical Physics. 39: 3948-3948. DOI: 10.1118/1.4736112 |
0.634 |
|
2011 |
Chao BH, Harrison MR, Kolesar J, Vanderhoek M, Perlman S, Eickhoff JC, Carmichael L, Alberti DB, Wilding G, Jeraj R, Liu G. Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13556. PMID 28022757 DOI: 10.1200/Jco.2011.29.15_Suppl.E13556 |
0.552 |
|
2011 |
Liu G, Jeraj R, Vanderhoek M, Perlman S, Kolesar J, Harrison M, Simoncic U, Eickhoff J, Carmichael L, Chao B, Marnocha R, Ivy P, Wilding G. Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7634-44. PMID 22038997 DOI: 10.1158/1078-0432.Ccr-11-1677 |
0.602 |
|
2011 |
Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R. Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leukemia Research. 35: 310-6. PMID 20832860 DOI: 10.1016/J.Leukres.2010.06.010 |
0.666 |
|
2011 |
Scully P, Jallow N, Vanderhoek M, Jeraj R. SU-E-J-87: Imaging Biomarkers of Treatment Response: A Roadmap to Validation Medical Physics. 38: 3462-3462. DOI: 10.1118/1.3611855 |
0.724 |
|
2011 |
Jallow N, Scully P, Vanderhoek M, Perlman S, Liu G, Jeraj R. SU-E-I-176: Impact of Residual Activity and Clock Synchronization on Quantitative Treatment Response Assessment Medical Physics. 38: 3437-3437. DOI: 10.1118/1.3611750 |
0.758 |
|
2011 |
Vanderhoek M, Perlman S, Jeraj R. SU-E-I-167: Impact of Peak SUV Definition on Quantification of Treatment Response Medical Physics. 38: 3434-3435. DOI: 10.1118/1.3611741 |
0.653 |
|
2010 |
Harrison MR, Jeraj R, Vanderhoek M, Simoncic U, Perlman S, Kolesar J, Eickhoff JC, Alberti DB, Wilding G, Liu G. Characterization of proliferative rebound during drug holiday by FLT-PET imaging in patients treated with sunitinib (SU). Journal of Clinical Oncology. 28: 3094-3094. DOI: 10.1200/Jco.2010.28.15_Suppl.3094 |
0.537 |
|
2010 |
Jeraj R, Liu G, Simoncic U, Vanderhoek M, Perlman S, Alberti DB, Harrison MR, Wilding G. Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI. Journal of Clinical Oncology. 28: 3050-3050. DOI: 10.1200/Jco.2010.28.15_Suppl.3050 |
0.513 |
|
2010 |
Titz B, Vanderhoek M, Simoncic U, Adhikarla V, Jeraj R. MO-E-BRB-05: A Computational Tumor Modeling Framework for the Optimization of Molecular Targeted Therapies Medical Physics. 37: 3356-3356. DOI: 10.1118/1.3469115 |
0.715 |
|
2010 |
Morrison C, Vanderhoek M, Perlman S, Jeraj R. MO-D-204B-05: Effect of PET Image Reconstruction Parameters on Quantitative Treatment Response Assessment Medical Physics. 37: 3342-3342. DOI: 10.1118/1.3469066 |
0.623 |
|
2010 |
Yip S, Vanderhoek M, Jeraj R. SU-GG-J-155: Impact of Deformable-Registration-Based Contour Propagation on PET Based Treatment Response Assessment Medical Physics. 37: 3181-3181. DOI: 10.1118/1.3468379 |
0.635 |
|
2010 |
Vanderhoek M, Lawrence J, Vail D, Jeraj R. SU-GG-J-151: Intra-Patient Response Heterogeneity Using FLT PET during Chemotherapy in Canine Subjects with Lymphoma Medical Physics. 37: 3180-3180. DOI: 10.1118/1.3468374 |
0.63 |
|
2009 |
Lawrence J, Vanderhoek M, Barbee D, Jeraj R, Tumas DB, Vail DM. Use of 3'-deoxy-3'-[18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 50: 660-8. PMID 19999354 DOI: 10.1111/J.1740-8261.2009.01612.X |
0.603 |
|
2009 |
Vail DM, Thamm DH, Reiser H, Ray AS, Wolfgang GH, Watkins WJ, Babusis D, Henne IN, Hawkins MJ, Kurzman ID, Jeraj R, Vanderhoek M, Plaza S, Anderson C, Wessel MA, et al. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3503-10. PMID 19417014 DOI: 10.1158/1078-0432.Ccr-08-3113 |
0.525 |
|
2009 |
Jeraj R, Vanderhoek M, Simoncic U, Perlman S, Alberti D, Wilding G, Liu G. WE-C-BRC-05: Use of FLT PET Imaging to Assess Tyrosine Kinase Inhibitor (TKI) Treatment Response Medical Physics. 36: 2761-2761. DOI: 10.1118/1.3182473 |
0.633 |
|
2009 |
Vanderhoek M, Perlman S, Liu G, Jeraj R. WE-C-BRC-04: Predictive Power of Various PET Measures for Treatment Response Assessment Medical Physics. 36: 2761-2761. DOI: 10.1118/1.3182472 |
0.639 |
|
2009 |
Jallow N, Vanderhoek M, Barbee D, Song C, Jeraj R. SU-FF-J-142: Sensitivity of Treatment Assessment to Different PET Normalization Techniques Medical Physics. 36: 2509-2509. DOI: 10.1118/1.3181434 |
0.753 |
|
2008 |
Liu G, Jeraj R, Perlman S, Vanderhoek M, Kolesar J, Eickhoff J, Alberti D, Wilding G. Pharmacodynamic study of FLT-PET imaging in patients treated with sunitinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3515. PMID 27949756 DOI: 10.1200/Jco.2008.26.15_Suppl.3515 |
0.586 |
|
2008 |
Juckett MB, Vanderhoek M, Perlman S, Nickles R, Jeraj R. A Pilot Study for Using 3′-Deoxy-3′-[ 18 f]Fluorothymidine Positron Emission Tomography ([18F]FLT PET/CT) Imaging for Early Assessment of Response to Induction Chemotherapy in Acute Myeloid Leukemia (AML) Blood. 112: 2550-2550. DOI: 10.1182/Blood.V112.11.2550.2550 |
0.645 |
|
2008 |
Vanderhoek M, Juckett M, Nickles R, Jeraj R. TH-D-AUD C-06: Early Assessment of Treatment Response in Hematopoietic Disease Using [18F]FLT PET Imaging Medical Physics. 35: 2987-2987. DOI: 10.1118/1.2962918 |
0.59 |
|
2007 |
Vanderhoek M, Barbee D, Jeraj R. TH-D-M100J-09: Activity Recovery From Dual Radiotracer PET Scans Medical Physics. 34: 2640-2640. DOI: 10.1118/1.2761718 |
0.586 |
|
2006 |
Vanderhoek M, Pyzalski R, Jaskowiak C, Jeraj R. TH-E-ValB-04: Dosimetric Impact of Changed FLT Uptake in AML Patients Treated with Chemotherapy Medical Physics. 33: 2290-2290. DOI: 10.1118/1.2241944 |
0.612 |
|
Show low-probability matches. |